Sign In
Last checked at 
19 May 2022 10:00
19 May 2022
ConvaTec Group Plc("ConvaTec" or "the Company")Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 18 May 2022, Jonny Mason, Chief Financial Officer and PDMR, purchased 22,000 Shares of 10 pence in the Company. Jonny Mason's resulting shareholding is 22,000 Shares.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||
a) | Name | Jonny Mason | ||
2 | Reason for the notification | |||
a) | Position/Status | Chief Financial Officer | ||
b) | Initial notification/Amendment | Initial notification | ||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
a) | Name | ConvaTec Group Plc | ||
b) | LEI | 213800LS272L4FIDOH92 | ||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary share of 10p each in ConvaTec Group Plc
GB00BD3VFW73 | ||
b) | Nature of the transaction | Purchase of Ordinary shares of 10p each in ConvaTec Group Plc
| ||
c) | Price(s) and volume(s) | Price(s) £2.238 | Volume(s) 22,000 | |
d) | Aggregated information - Aggregated volume - Price |
n/a n/a | ||
e) | Date of the transaction | 2022-05-18 | ||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
Follow the stocks
